Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.

Ann Hematol · 2019 · PMC6900267 · PMID 31745601

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

There was also a clear trend for male sex to be an independent risk factor for both endpoints (Online Resource Fig. 1a, b ).

also in 19,460 other papers

a strong trendno p-value reported

There was a strong trend for advanced disease stage to be associated with decreased survival outcomes (Online Resource Fig. 1a, b ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.